Amedisys (NASDAQ: AMED) reported Q2 EPS of $1.02, $0.03 better than the analyst estimate of $0.99. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE